Acetylon Pharmaceuticals entered into an agreement to be acquired by Celgene Corporation
Saturday, December 03, 2016
Acetylon Pharmaceuticals -Regenacy Pharmaceuticals to be launched by Acetylon Pharmaceuticals and Celgene Corporation agrees to complete acquisition of acetylon.
Acetylon Pharmaceuticals - entered into an agreement to be acquired by Celgene Corporation.
Acetylon Pharmaceuticals - financial terms of acquisition are not being disclosed.
Acetylon- key members of co executive team will join Regenacy, which will operate out of Acetylon's former headquarters in Boston's Seaport District.
Acetylon Pharmaceuticals - prior to consummation of acquisition, Acetylon will spin out a new company, Regenacy Pharmaceuticals, LLC.
Acetylon Pharma-Regenacy will receive worldwide rights to co's phase 2 selective histone deacetylase 6 (HDAC6) inhibitor, ricolinostat, among others.
Source : reuters.com
